Skip to main content
OpenTrials

Clinical trial condition

Mood Disorders

Explore clinical trials studying Mood Disorders. Study availability and eligibility vary by location and protocol.

4,266 public trials 601 recruiting studies
Refine in advanced search Browse all conditions

Mood Disorders trial results

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

NCT02417064

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +2 more
Locations
  • Birmingham, Alabama, United States
  • Little Rock, Arkansas, United States
  • Garden Grove, California, United States
  • Orange, California, United States
View all 90 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

NCT02418585

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +2 more
Locations
  • Birmingham, Alabama, United States
  • Orange, California, United States
  • San Rafael, California, United States
  • Maitland, Florida, United States
View all 48 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide

NCT03185819

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • Institute of Living/ Hartford Hospital Hartford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • Atlanta Behavioral Research, LLC Atlanta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 51 locations
View Trial Details
Completed

A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

NCT03321526

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • NoesisPharma Research Phoenix, Arizona, United States
  • Clinical Research Consortium Arizona Tempe, Arizona, United States
  • Woodland Research Northwest Rogers, Arkansas, United States
  • Collaborative NeuroScience Network Garden Grove, California, United States
View all 50 locations
View Trial Details
Completed

A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide

NCT02133001

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Birmingham, Alabama, United States
  • San Diego, California, United States
  • Hartford, Connecticut, United States
  • New Haven, Connecticut, United States
View all 14 locations
View Trial Details

Related conditions